Autolus Therapeutics plc ADR
Autolus Therapeutics plc ADR (AUTL) Unusual Options Activity Today
AUTL options volume power reached 0.01x on the previous trading day. The highest reading was on the $2 CALL expiring 2027-03-19.
Read more
Checking AUTL unusual options activity helps you spot when traders are making outsized bets on Autolus Therapeutics plc ADR before the broader market catches on. Autolus Therapeutics plc ADR's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor AUTL unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching AUTL unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking AUTL unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and AUTL unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1; AUTO6NG, a programmed T cell investigational therapy, which is in preclinical trail targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate that is in a Phase I clinical trial for multiple myeloma.
It also focuses on developing AUTO5, a hematological product candidate, which is in preclinical development. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.
Catalysts rarely arrive without a footprint, and AUTL unusual options activity is often where that footprint shows up first. Our scanner tracks Autolus Therapeutics plc ADR's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at AUTL unusual options volume on the call side or chasing put sweeps, Autolus Therapeutics plc ADR's unusual options flow today is one click away, so put it on your radar before the headlines hit.
| 0.50 | 0.90 | 1.90 | 1.40 | 531% | 0 | 0 | — |
| 1.00 | 0.45 | 1.45 | 0.95 | 353% | 0 | 2 | 0.00% |
| 1.50 | 0.05 | 1.05 | 0.55 | 262% | 0 | 0 | — |
| 2.00 | — | 0.75 | 0.75 | 562% | 0 | 224 | 0.00% |
| 2.50 | — | 1.00 | 1.00 | 841% | 0 | 0 | — |
| 0.50 | — | 1.00 | 1.00 | 1,000% | 0 | 0 | — |
| 1.00 | — | 1.00 | 1.00 | 1,000% | 0 | 0 | — |
| 1.50 | — | 1.00 | 1.00 | 1,000% | 0 | 0 | — |
| 2.00 | — | 1.00 | 1.00 | 643% | 0 | 0 | — |
| 2.50 | 0.15 | 1.15 | 0.65 | 80% | 0 | 102 | 0.00% |
As of October 1, 2026
Spot unusual options activity before it moves
Track AUTL options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.
Start your 14-day free trial→